Association Between Mutation Size and Cardiac Involvement in Myotonic Dystrophy Type 1: An Analysis of the DM1-Heart Registry

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Circulation: Cardiovascular Genetics

• Publication date

  2017-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/CIRCGENETICS.116.001526PMID 28611030
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Splicing misregulation of SCN5A contributes to cardiac-conduction delay and heart arrhythmia in myotonic dystrophy

  2016influential reference
• Electrophysiological study with prophylactic pacing and survival in adults with myotonic dystrophy and conduction system disease.

  2012influential reference
• Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2

  2012influential reference
• Survival and CTG repeat expansion in adults with myotonic dystrophy type 1

  2011cited by this paper
• AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part V: electrocardiogram changes associated with cardiac chamber hypertrophy: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinic

  2009cited by this paper
• Usefulness of clinical and electrocardiographic data for predicting adverse cardiac events in patients with myotonic dystrophy.

  2009influential reference
• AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part III: intraventricular conduction disturbances: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American

  2009cited by this paper
• The CTG repeat expansion size correlates with the splicing defects observed in muscles from myotonic dystrophy type 1 patients

  2008cited by this paper
• ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echoca

  2003cited by this paper
• ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echoca

  2003cited by this paper
• Severity of Cardiac Conduction Involvement and Arrhythmias in Myotonic Dystrophy Type 1 Correlates with Age and CTG Repeat Length

  2002influential reference
• Long-term follow-up of arrhythmias in patients with myotonic dystrophy treated by pacing: a multicenter diagnostic pacemaker study.

  2002influential reference
• Does cytosine-thymine-guanine (CTG) expansion size predict cardiac events and electrocardiographic progression in myotonic dystrophy?

  2001influential reference
• Assessment of a disease-specific muscular impairment rating scale in myotonic dystrophy

  2001influential reference
• New nomenclature and DNA testing guidelines for myotonic dystrophy type 1 (DM1)

  2000cited by this paper
• Natural history of cardiac involvement in myotonic dystrophy: Correlation with CTG repeats

  2000cited by this paper
• Relationships among electrophysiological findings and clinical status, heart function, and extent of DNA mutation in myotonic dystrophy.

  1999influential reference
• A 10-year study of mortality in a cohort of patients with myotonic dystrophy

  1999cited by this paper
• Correlation between cardiac involvement and CTG trinucleotide repeat length in myotonic dystrophy.

  1995cited by this paper
• Relationship between parental trinucleotide GCT repeat length and severity of myotonic dystrophy in offspring.

  1993influential reference
• Correlation between CTG trinucleotide repeat length and frequency of severe congenital myotonic dystrophy

  1992influential reference
• Cloning of the essential myotonic dystrophy region and mapping of the putative defect

  1992cited by this paper
• Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene.

  1992influential reference
• Malaria, bednets, and mortality.

  1991influential reference
• Clinical Classification of Cardiac Deaths

  1982cited by this paper

• Atrial Fibrillation and Flutter in a Contemporary Cohort of Patients With Myotonic Muscular Dystrophy.

  2025cites this paper
• Genetic anticipation and cardiac conduction abnormalities in myotonic dystrophy type 1: implications for early stratification from a multicenter registry

  2025influential citation
• Cardiac Involvement in Myotonic Dystrophy Type 1: Mechanisms, Clinical Perspectives, and Emerging Therapeutic Strategies

  2025cites this paper
• Predictors of respiratory failure and survival in myotonic dystrophy type 1.

  2025cites this paper
• Zero fluoroscopy catheter ablation of maternal atrial arrhythmias during pregnancy in a patient with myotonic dystrophy

  2025cites this paper
• Gender disparities in myotonic dystrophy 1.

  2025cites this paper
• Management of Maternal Genetic Conditions in Pregnancy, Part 1: Disorders of the Connective Tissue, Muscle, Vascular, and Skeletal Systems

  2025cites this paper
• Is Cardiac Transplantation Still a Contraindication in Patients with Muscular Dystrophy-Related End-Stage Dilated Cardiomyopathy? A Systematic Review

  2024cites this paper
• Calcium handling abnormalities increase arrhythmia susceptibility in DMSXL myotonic dystrophy type 1 mice.

  2024cites this paper
• CTG repeat length underlying cardiac events and sudden death in myotonic dystrophy type 1

  2024cites this paper
• Natural history of cardiac involvement in myotonic dystrophy type 1 - Emphasis on the need for lifelong follow-up.

  2024cites this paper
• Cardiac involvement in patient-specific induced pluripotent stem cells of myotonic dystrophy type 1: unveiling the impact of voltage-gated sodium channels

  2023cites this paper
• The current status of medical care for myotonic dystrophy type 1 in the national registry of Japan

  2023cites this paper
• 2022 HRS expert consensus statement on evaluation and management of arrhythmic risk in neuromuscular disorders.

  2022cites this paper
• 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death.

  2022cites this paper
• Arrhythmic CArdiac DEath in MYotonic dystrophy type 1 patients (ACADEMY 1) study: the predictive role of programmed ventricular stimulation.

  2022cites this paper
• Case Report: Severe Peripartum Cardiac Disease in Myotonic Dystrophy Type 1

  2022cites this paper
• Mice lacking MBNL1 and MBNL2 exhibit sudden cardiac death and molecular signatures recapitulating myotonic dystrophy

  2022influential citation
• Genetic Testing in Sudden Cardiac Arrest: the History and Physical Exam Remain Central in the Genomics Era.

  2022cites this paper
• Electrophysiologic Consequences and Sudden Death in Myotonic Dystrophy: Beyond the ECG and Toward Precision Medicine.

  2021cites this paper
• iPSC-derived cardiomyocytes from patients with myotonic dystrophy type 1 have abnormal ion channel functions and slower conduction velocities

  2021cites this paper
• Reversible cardiac disease features in an inducible CUG repeat RNA–expressing mouse model of myotonic dystrophy

  2021cites this paper
• Deciphering the mechanisms underlying brain alterations and cognitive impairment in congenital myotonic dystrophy.

  2021cites this paper
• Cardiac Pathology in Myotonic Dystrophy Type 1

  2021cites this paper
• Cardiovascular manifestations of myotonic dystrophy.

  2020cites this paper
• Design of novel small molecule base-pair recognizers of toxic CUG RNA transcripts characteristics of DM1

  2020cites this paper
• Predictors of prognosis in type 1 myotonic dystrophy (DM1): longitudinal 18-years experience from a single center

  2020cites this paper
• Gender effect on cardiac involvement in myotonic dystrophy type 1

  2020cites this paper
• Preliminary Findings on CTG Expansion Determination in Different Tissues from Patients with Myotonic Dystrophy Type 1

  2020cites this paper
• Cardiac Conduction Disorders as Markers of Cardiac Events in Myotonic Dystrophy Type 1

  2020cites this paper
• Predictors of respiratory decline in myotonic dystrophy type 1 (DM1): a longitudinal cohort study

  2020cites this paper
• Predictors of respiratory decline in myotonic dystrophy type 1 (DM1): a longitudinal cohort study

  2020cites this paper
• Biophysical mechanisms for QRS- and QTc-interval prolongation in mice with cardiac expression of expanded CUG-repeat RNA

  2020cites this paper
• DM1 Phenotype Variability and Triplet Repeat Instability: Challenges in the Development of New Therapies

  2020cites this paper
• Mutation analysis of multiple pilomatricomas in a patient with myotonic dystrophy type 1 suggests a DM1-associated hypermutation phenotype

  2019cites this paper
• The Added Value of Cardiac Magnetic Resonance in Muscular Dystrophies

  2019cites this paper
• Modelling the pathogenesis of Myotonic Dystrophy type 1 cardiac phenotype through human iPSC-derived cardiomyocytes.

  2018cites this paper
• Hypersomnolence secondaire à une dystrophie myotonique de type 1 sans myotonie clinique

  2018cites this paper
• Cardiac Involvements in Myotonic Dystrophy

  2018cites this paper
• [Dystrophic and non-dystrophic myotonias].

  2018cites this paper
• Core Clinical Phenotypes in Myotonic Dystrophies

  2018cites this paper
• AFM nano‐mechanical study of the beating profile of hiPSC‐derived cardiomyocytes beating bodies WT and DM1

  2018cites this paper
• A 34-year longitudinal study on long-term cardiac outcomes in DM1 patients with normal ECG at baseline at an Italian clinical centre

  2018cites this paper
• Gene Editing and Gene-Based Therapeutics for Cardiomyopathies.

  2018cites this paper
• Repeats and Survival in Myotonic Dystrophy Type 1.

  2017cites this paper